Successes and Failures of Stem Cell Transplantation in Autoimmune Diseases
- 10 December 2011
- journal article
- review article
- Published by American Society of Hematology in Hematology
- Vol. 2011 (1), 280-284
- https://doi.org/10.1182/asheducation-2011.1.280
Abstract
Over the past 15 years, more than 1500 patients have received HSCT, mostly autologous, as treatment for a severe autoimmune disease (AD). More than 1000 of these have been registered in the European Group for Bone Marrow Transplantation (EBMT) and European League Against Rheumatism (EULAR) combined database. A recent retrospective analysis of 900 patients showed that the majority had multiple sclerosis (MS; n = 345) followed by systemic sclerosis (SSc; n = 175), systemic lupus erythematosus (SLE; n = 85), rheumatoid arthritis (RA; n = 89), juvenile idiopathic arthritis (JIA; n = 65), and idiopathic cytopenic purpura (ITP; n = 37). An overall 85% 5-year survival and 43% progression-free survival was seen, with 100-day transplantation-related mortality (TRM) ranging between 1% (RA) and 11% (SLE and JIA). Approximately 30% of patients in all disease subgroups had a complete response, often durable despite full immune reconstitution. In many patients, such as in those with SSc, morphological improvement such as reduction of skin collagen and normalization of microvasculature was documented beyond any predicted known effects of intense immunosuppression alone. The high TRM was in part related to conditioning intensity, comorbidity, and age, but until the results of the 3 prospective randomized trials are known, an evidence-based modification of the conditioning regimen will not be possible.1 In recent years, multipotent mesenchymal stromal cells (MSCs) have been tested in various AD, exploiting their immune-modulating properties and apparent low acute toxicity. Despite encouraging small phase 1/2 studies, no positive data from randomized, prospective studies are as yet available in the peer-reviewed literature.Keywords
This publication has 44 references indexed in Scilit:
- Nail fold capillaroscopy differs widely between systemic sclerosis and chronic graft vs host disease of the skinRheumatology, 2011
- Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune DiseasesHaematologica, 2009
- Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune systemBlood, 2009
- Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?PLOS ONE, 2008
- Regulatory T cells in autologous stem cell transplantation for autoimmune diseaseAutoimmunity, 2008
- Skin involvement in scleroderma--where histological and clinical scores meetRheumatology, 2007
- Autologous hematopoietic stem cell transplantation for autoimmune diseasesBone Marrow Transplantation, 2005
- Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patientsThe Journal of Experimental Medicine, 2005
- Blood and marrow stem cell transsplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)Bone Marrow Transplantation, 1997
- Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease.Annals Of The Rheumatic Diseases, 1996